New foundational therapy in heart failure with reduced ejection fraction: should we keep following the 2016 European Society of Cardiology Heart Failure Guideline in 2021?

Back

ESC Premium Access

New foundational therapy in heart failure with reduced ejection fraction: should we keep following the 2016 European Society of Cardiology Heart Failure Guideline in 2021?

Session: Highlights from the Young in heart failure

Topic: Pharmacotherapy

Speaker: Doctor J. Brito (Lisbon, PT)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Doctor Joana Brito

Santa Maria University Hospital CHLN Lisbon Academic Medical Centre, Lisbon (Portugal)

0 follower

4 more presentations in this session

Machine learning to aid in the diagnosis of acute heart failure in the emergency department

Speaker: Mr D. Doudesis (Edinburgh, GB)

Implication of sphingolipid metabolism gene dysregulation and cardiac sphingosine-1-phosphate accumulation in heart failure

Speaker: Miss L. Perez Carrillo (Valencia, ES)

Age- and Sex-Specific Rates of Heart Failure and other Adverse Cardiovascular Outcomes in Systemic Sclerosis

Speaker: Doctor G. Sun (Copenhagen, DK)

Applying the ESC 2016, the H2FPEF, and the HFA-PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the general population - a comparative approach

Speaker: Doctor J. Nikorowitsch (Hamburg, DE)

Access the full session

Highlights from the Young in heart failure

Speakers: Doctor J. Brito, Mr D. Doudesis, Miss L. Perez Carrillo, Doctor G. Sun, Doctor J. Nikorowitsch

Access

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources